HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Sánchez-Criado, J. E Articles by de las Mulas, J. M. Search for Related Content PubMed PubMed Citation Articles by Sánchez-Criado, J. E Articles by de las Mulas, J. M.

Department of Cell Biology, Physiology and Immunology, University of Córdoba, Avda. Menendez Pidal s/n, 14004 Córdoba, Spain
¹ Department of Physiology, University of La Laguna, La Laguna, Spain
² Department of Comparative Pathology, University of Córdoba, Córdoba, Spain

(Requests for offprints should be addressed to J E Sánchez-Criado; Email: fi1sacrj{at}uco.es)

In the rat, administration of tamoxifen (TX) in the absence of oestrogen (E) induces LHRH self-priming, the progesterone receptor (PR)-dependent property of LHRH that increases gonadotrope responsiveness to itself. The oestrogen-dependent PR can be phosphorylated/activated by progesterone (P₄) and, in the absence of the cognate ligand, by intracellular LHRH signals, particularly cAMP/protein kinase A. We have recently found that oestradiol-17ß (E₂), acting on a putative membrane estrogen receptor- in the gonadotrope, inhibits this agonist action of TX. This study investigated the mechanism by which E₂ inhibits TX-elicited LHRH self-priming using both incubated pituitaries from TX-treated ovariectomized (OVX) rats and anterior pituitary cells from OVX rats cultured with TX. It was found that (1) in addition to the inhibitory effect on TX-elicited LHRH self-priming, E₂ blocked P₄ and adenylyl cyclase activator forskolin augmentation of LHRH-stimulated LH secretion, and (2) E₂ did not affect the increasing action of TX on gonadotrope PR expression or pituitary cAMP content. Furthermore, inhibition of protein phosphatases with okadaic acid suppressed E₂ inhibition of TX-elicited LHRH-induced LH secretion, while stimulation of protein phosphatases with ceramide blocked TX-induced LHRH self-priming. Together, these results indicated that membrane ER-mediated E₂ inhibition of the TX-stimulated LHRH self-priming pathway involves a blockade of gonadotrope PR phosphorylation/activation, but not a deficient response of PR to phosphorylases. Results also suggested that the inhibitory effect of E₂on TX-induced LHRH self-priming is exerted through modulation of cellular protein phosphatase activity in the gonadotrope.

This article has been cited by other articles:

				A. Gordon, J. C Garrido-Gracia, R. Aguilar, C. Bellido, J. A G. Velasco, Y. Millan, M. Tena-Sempere, J. Martin de las Mulas, and J. E Sanchez-Criado The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression J. Endocrinol., March 1, 2008; 196(3): 583 - 592. [Abstract] [Full Text] [PDF]

				J. C Garrido-Gracia, A. Gordon, C. Bellido, R. Aguilar, I. Barranco, Y. Millan, J. M. de las Mulas, and J. E Sanchez-Criado The integrated action of oestrogen receptor isoforms and sites with progesterone receptor in the gonadotrope modulates LH secretion: evidence from tamoxifen-treated ovariectomized rats J. Endocrinol., April 1, 2007; 193(1): 107 - 119. [Abstract] [Full Text] [PDF]